Supplemental material
Modern Rheumatology
Volume 29, 2019 - Issue 2
Open access
1,370
Views
3
CrossRef citations to date
0
Altmetric
Original Article
Efficacy and safety of sirukumab in Japanese patients with active rheumatoid arthritis who were refractory or intolerant to anti-tumor necrosis factor therapy: Subgroup analysis of a randomized, double-blind, multicenter, phase 3 study (SIRROUND-T)
Yoshiya TanakaFirst Department of Internal Medicine, School of Medicine, University of Occupational & Environmental Health Japan, Kitakyushu, Japan; View further author information
, Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan; View further author information
, Masayoshi HarigaiDepartment of Epidemiology and Pharmacoepidemiology, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan; View further author information
, Hisashi YamanakaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; View further author information
, Toshikazu NakanoJanssen Pharmaceutical K.K., Tokyo, Japan; View further author information
, Koshiro AkagiJanssen Pharmaceutical K.K., Tokyo, Japan; View further author information
, Yoshifumi UkyoJanssen Pharmaceutical K.K., Tokyo, Japan; View further author information
& Benjamin HsuJanssen Research & Development, LLC, Spring House, PA, USACorrespondence[email protected]
http://orcid.org/0000-0002-0718-213XView further author information
Pages 306-313
|
Received 16 Jan 2018, Accepted 04 Mar 2018, Published online: 13 Apr 2018
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.